The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study
Abstract
Understanding the mechanisms of outcome according to the time frame can help optimize the therapeutic development in severe alcoholic hepatitis. We assessed short‐term and long‐term survival in severe alcoholic hepatitis based on baseline disease severity, extent of therapeutic improvement, long‐term influence of alcohol relapse, and their interaction. Data and alcohol consumption were prospectively recorded in 398 patients treated with corticosteroids in the short term (from corticosteroid initiation to 6 months) and long term (from 6 months to maximum follow‐up time). Cumulative incidence rate of first alcohol relapse was 25.2%, 33.7%, and 35.2% at 1, 3, and 5 years, respectively. Alcohol relapse (≥30 g/day) was not associated with mortality ( P = 0.24) during the short‐term period (1,606 patient‐months at risk), but the Lille ( P < 0.0001) and Model for End‐Stage Liver Disease ( P < 0.0001) scores were independent prognostic factors. In patients who were alive at 6 months (median follow‐up, 42 months; interquartile range 11‐88), corresponding to 10,413 patient‐months at risk, alcohol consumption (≥30 g/day) was associated with mortality (hazard ratio, 3.9; P < 0.0001). Additional analysis with abstinent patients as a reference showed a dose effect of alcohol on the hazard ratio of death: 2.36 ( P = 0.052) for 1‐29 g/day, 3.2 ( P = 0.003) for 30‐49 g/day, 3.51 ( P < 0.0001) for 50‐99 g/day, and 5.61 ( P < 0.0001) for ≥ 100 g/day. The baseline Model for End‐Stage Liver Disease score was not predictive of long‐term outcome, while Lille score ( P = 0.02) and alcohol relapse ( P < 0.0001) were independent prognostic factors. Conclusion : This study shows that new therapeutic development for severe alcoholic hepatitis must target liver injury in the short term and alcohol consumption in the long term; thus, health agencies can endorse future study designs adapted to the time frame of factors influencing mortality; with this in mind, drug‐targeting mechanisms involved in liver injury should only be tested for the short‐term period. (H epatology 2017;66:1464–1473)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
Partial residuals for the proportional hazards regression model
SCHOENFELD, D. (1982) · Biometrika · doi:10.1093/biomet/69.1.239 · Cited by 3,111
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
Long-term follow-up after tight control of blood pressure in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Neil, H. A. W., & Matthews, D. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806359 · Cited by 762
Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease
Zakhari, S., & Li, T.-K. (2007) · Hepatology · doi:10.1002/hep.22010 · Cited by 333
Cited by
ACG Clinical Guideline: Alcoholic Liver Disease
Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S., & Shah, V. H. (2018) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.469 · Cited by 835
Diagnosis and Treatment of Alcohol-Associated Liver Disease: A Review
Singal, A. K., & Mathurin, P. (2021) · JAMA · doi:10.1001/jama.2021.7683 · Cited by 398
Self-citationAlcohol-associated liver disease—Global epidemiology
Åberg, F., Jiang, Z. G., Cortez-Pinto, H., & Männistö, V. (2024) · Hepatology · doi:10.1097/hep.0000000000000899 · Cited by 163
Management of alcohol use disorder in patients with chronic liver disease
Mellinger, J. L., Fernandez, A. C., & Winder, G. S. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000145 · Cited by 52
Lucey, M. R. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.09.013 · Cited by 39
Metadata
- Authors
- Louvet, A., Labreuche, J., Artru, F., Bouthors, A., Rolland, B., Saffers, P., Lollivier, J., Lemaître, E., Dharancy, S., Lassailly, G., Canva‐Delcambre, V., Duhamel, A., & Mathurin, P.
- Venue
- Hepatology
- Published
- 2017-09-26
- Volume
- 66
- Issue
- 5
- Pages
- 1464-1473
- ISSN
- 0270-9139 (ISSN-L)
- 1527-3350
- OpenAlex
- W2608495636
- Cited by
- 218
- References
- 5
- FWCI
- 11.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. https://app.cochat.ai/papers/10.1002/hep.29240
- The paper
- Louvet, A., Labreuche, J., Artru, F., Bouthors, A., Rolland, B., Saffers, P., Lollivier, J., Lemaître, E., Dharancy, S., Lassailly, G., Canva‐Delcambre, V., Duhamel, A., & Mathurin, P. (2017). Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study. Hepatology. https://doi.org/10.1002/hep.29240
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.